Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 713 (USA) (Dr. Kowalski)
· consented 2014-03-30
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-14 (study day 107.0); relationship: PROBABLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.